Zobrazeno 1 - 10
of 13
pro vyhledávání: '"De Miguel Luken MJ"'
Autor:
Papadatos-Pastos D, Roda D, De Miguel Luken MJ, Petruckevitch A, Jalil A, Capelan M, Michalarea V, Lima J, Diamantis N, Bhosle J, Molife LR, Banerji U, de Bono JS, Popat S, O'Brien MER, Yap TA
Publikováno v:
European journal of cancer (Oxford, England : 1990)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a1f85933511a33110121dafd490d9aea
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1508
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1508
Autor:
Ghalib MH; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA.; Now at Rutgers Cancer Institute, New Brunswick, NJ, USA., Pulla MP; Dept. Servicio de Oncología Médica, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain., De Miguel Luken MJ; Early Phase Clinical Trial Unit, Hospital Madrid Norte San Chinarro - Centro Integral Oncologico Clara Campal, Madrid, Spain., de Juan VC; Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain., Chaudhary I; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Hammami MB; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Vikash S; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Maitra R; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Martinez S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain., Kahatt C; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain., Extremera S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain., Fudio S; Clinical Development, PharmaMar, Colmenar Viejo, Madrid, S.A, Spain., Goel S; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA. sanjay.goel@rutgers.edu.; Now at Rutgers Cancer Institute, New Brunswick, NJ, USA. sanjay.goel@rutgers.edu.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Oct; Vol. 42 (5), pp. 481-491. Date of Electronic Publication: 2024 Aug 03.
Autor:
Kim TW; Asan Medical Center, University of Ulsan, Seoul, Korea., Burris HA; Sarah Cannon Research Institute, Nashville, Tennessee., de Miguel Luken MJ; START-CIOCC, Hosp. HM Sanchinarro, Madrid, Spain., Pishvaian MJ; Johns Hopkins University School of Medicine, Washington, DC., Bang YJ; Seoul National University College of Medicine, Seoul, Korea., Gordon M; HonorHealth Research Institute, Scottsdale, Arizona., Awada A; Jules Bordet Institute, Brussels, Belgium., Camidge DR; University of Colorado Anschutz Medical Campus, Aurora, Colorado., Hodi FS; Dana-Farber Cancer Institute, Boston, Massachusetts., McArthur GA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia., Miller WH; Jewish General Hospital and Segal Cancer Centre, McGill University, Montréal, Canada., Cervantes A; Biomedical Research Institute INCLIVA, University of Valencia, Valencia Spain., Chow LQ; University of Washington, Seattle, Washington., Lesokhin AM; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, New York, New York., Rutten A; GasthuisZusters Antwerpen Sint-Augustinus, Antwerp, Belgium., Sznol M; Yale School of Medicine, New Haven, Connecticut., Rishipathak D; Genentech, Inc., South San Francisco, California., Chen SC; Genentech, Inc., South San Francisco, California., Stefanich E; Genentech, Inc., South San Francisco, California., Pourmohamad T; Genentech, Inc., South San Francisco, California., Anderson M; Genentech, Inc., South San Francisco, California., Kim J; Genentech, Inc., South San Francisco, California., Huseni M; Genentech, Inc., South San Francisco, California., Rhee I; Genentech, Inc., South San Francisco, California., Siu LL; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 15; Vol. 28 (16), pp. 3452-3463.
Autor:
Moreno V; START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain. Electronic address: victor.moreno@startmadrid.com., Garrido P; Medical Oncology Department, IRYCIS, Hospital Universitario Ramón y Cajal, Madrid, Spain., Papadopoulos KP; START, San Antonio, TX, USA., De Miguel Luken MJ; Centro Integral Oncológico Clara Campal, Hospital Universitario HM Sanchinarro, Madrid, Spain., Gil-Martin M; Institut Català D'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Aljumaily R; Stephenson Cancer Center of the University of Oklahoma, Oklahoma City, OK, USA; Sarah Cannon Research Institute, Nashville, TN, USA., Rosen LS; UCLA Division of Hematology-Oncology, Santa Monica, CA, USA., Rietschel P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Mohan KK; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Yoo SY; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Stankevich E; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2021 May; Vol. 155, pp. 151-155. Date of Electronic Publication: 2021 Mar 04.
Autor:
Hurtado FK; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. felipe.kellermann_hurtado@novartis.com., de Braud F; Fondazione IRCCS-Istituto Nazionale Dei Tumori, Milano, Italy., De Castro Carpeño J; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., de Miguel Luken MJ; CIOCC-Grupo Hospitalario de Madrid, Hosp. de Sanchinarro, Madrid, Spain., Wang D; Henry Ford Cancer Institute, Detroit, MI, USA., Scott J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Lau YY; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., McCulloch T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Mau-Sorensen M; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Apr; Vol. 87 (4), pp. 475-486. Date of Electronic Publication: 2021 Jan 04.
Autor:
Yap TA; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom., O'Carrigan B; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Penney MS; Vertex Pharmaceuticals, Boston, MA., Lim JS; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Brown JS; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., de Miguel Luken MJ; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Tunariu N; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Perez-Lopez R; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., Rodrigues DN; The Institute of Cancer Research, London, United Kingdom., Riisnaes R; The Institute of Cancer Research, London, United Kingdom., Figueiredo I; The Institute of Cancer Research, London, United Kingdom., Carreira S; The Institute of Cancer Research, London, United Kingdom., Hare B; Vertex Pharmaceuticals, Boston, MA., McDermott K; Vertex Pharmaceuticals, Boston, MA., Khalique S; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Williamson CT; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Natrajan R; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Pettitt SJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Lord CJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom., Banerji U; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom., Pollard J; Vertex Pharmaceuticals, Oxfordshire, United Kingdom., Lopez J; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom., de Bono JS; Drug Development Unit, Royal Marsden Hospital, London, United Kingdom.; The Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Sep 20; Vol. 38 (27), pp. 3195-3204. Date of Electronic Publication: 2020 Jun 22.
Autor:
Hyman DM; Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Tran B; Royal Melbourne Hospital, Melbourne, VIC, Australia., Paz-Ares L; Hospital Universitario Virgen del Rocío, Seville, Spain., Machiels JP; Institut Roi Albert II, Brussels, Belgium.; Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Institut de Recherche Clinique et Expérimentale, Brussels, Belgium.; Université Catholique de Louvain, Brussels, Belgium., Schellens JH; The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bedard PL; University Health Network, Toronto, Ontario, Canada., Campone M; René Gauducheau Centre de Recherche en Cancérologie, Nantes, France., Cassier PA; Centre Regional Leon-Berard, Lyon, France., Sarantopoulos J; University of Texas Health Science Center San Antonio, San Antonio, TX., Vaishampayan U; Wayne State University, Detroit, MI., Chugh R; University of Michigan, Ann Arbor, MI., Mahipal A; Moffitt Cancer Center, Tampa, FL., Lockhart AC; Washington University School of Medicine, St Louis, MO., Sessa C; Ospedale San Giovanni, Bellinzona, Switzerland., Zander T; University Hospital Cologne, Cologne, Germany., Ng M; National Cancer Centre Singapore, Singapore., Curigliano G; University of Milano, Milan, Italy.; European Institute of Oncology, IRCCS, Milan, Italy., Bendiske J; Novartis Pharmaceuticals, East Hanover, NJ., Chen X; Novartis Pharmaceuticals, East Hanover, NJ., Choudhury S; Novartis Pharmaceuticals, East Hanover, NJ., Graus-Porta D; Novartis Pharma AG, Basel, Switzerland., Lewis N; Novartis Pharmaceuticals, East Hanover, NJ., Perez Garcia JM; Vall D'Hebron Institute of Oncology, Barcelona, Spain., de Miguel-Luken MJ; HM Universitario Sanchinarro, Madrid, Spain.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2019 Dec; Vol. 3, pp. 1-13.
Autor:
de Miguel-Luken MJ; aSTART Madrid-Centro Integral Oncológico Clara Campal, Sanchinarro University Hospital, Madrid, Spain bCentro Hospitalar Lisboa Norte EPE, Hospital de Santa Maria, Oncology Department, Lisbon, Portugal., Mansinho A, Boni V, Calvo E
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2017 Sep; Vol. 29 (5), pp. 382-394.
Autor:
de Miguel-Luken MJ; Department of Medical Oncology, Virgen del Rocío University Hospital, Seville, Spain., Chaves-Conde M; Department of Medical Oncology, Virgen del Rocío University Hospital, Seville, Spain., Quintana B; Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain., Menoyo A; Department of Otorhinolaryngology, Virgen del Rocío University Hospital, Seville, Spain., Tirado I; Department of Otorhinolaryngology, Virgen del Rocío University Hospital, Seville, Spain., de Miguel-Luken V; University of Málaga, Málaga, Spain., Pachón J; Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain., Chinchón D; Department of Pathology, Virgen del Rocío University Hospital, Seville, Spain., Suarez V; Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain., Carnero A; Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío/ Universidad de Sevilla/ Consejo Superior de Investigaciones Científicas, Seville, Spain.
Publikováno v:
Oncotarget [Oncotarget] 2016 May 31; Vol. 7 (22), pp. 31723-37.
Autor:
de Miguel-Luken MJ; a Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas , Seville , Spain.; b Department of Medical Oncology , Virgen del Rocío University Hospital , Seville , Spain., Chaves-Conde M; a Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas , Seville , Spain.; b Department of Medical Oncology , Virgen del Rocío University Hospital , Seville , Spain., Carnero A; a Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas , Seville , Spain.
Publikováno v:
Cell cycle (Georgetown, Tex.) [Cell Cycle] 2016 May 02; Vol. 15 (9), pp. 1202-12. Date of Electronic Publication: 2016 Mar 03.